Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) shares reached a new 52-week high on Thursday . The stock traded as high as $8.45 and last traded at $8.37, with a volume of 315834 shares. The stock had previously closed at $8.26.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on AVAH shares. Wall Street Zen raised shares of Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Truist Financial cut their target price on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. UBS Group upgraded Aveanna Healthcare from a "sell" rating to a "neutral" rating and upped their price objective for the stock from $6.75 to $8.00 in a research report on Tuesday, August 19th. Jefferies Financial Group upgraded Aveanna Healthcare from a "hold" rating to a "buy" rating and dropped their price objective for the stock from $6.25 to $6.00 in a research report on Monday, July 21st. Finally, Raymond James Financial raised shares of Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 target price for the company in a report on Monday, August 11th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, Aveanna Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $7.50.
Check Out Our Latest Analysis on AVAH
Aveanna Healthcare Stock Up 1.9%
The company's 50 day moving average price is $5.79 and its 200-day moving average price is $5.25. The stock has a market cap of $1.76 billion, a P/E ratio of 105.25 and a beta of 2.04.
Insiders Place Their Bets
In other news, insider Patrick A. Cunningham sold 18,500 shares of the business's stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $4.93, for a total transaction of $91,205.00. Following the completion of the sale, the insider owned 327,869 shares in the company, valued at $1,616,394.17. The trade was a 5.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 7.80% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Summit Partners L P bought a new position in Aveanna Healthcare during the second quarter worth about $50,477,000. First Eagle Investment Management LLC boosted its holdings in Aveanna Healthcare by 12.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 810,667 shares of the company's stock worth $4,240,000 after buying an additional 87,500 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Aveanna Healthcare by 103.9% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 664,890 shares of the company's stock worth $3,477,000 after buying an additional 338,746 shares during the period. Jacobs Levy Equity Management Inc. boosted its holdings in Aveanna Healthcare by 50.1% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after buying an additional 177,856 shares during the period. Finally, Squarepoint Ops LLC boosted its holdings in shares of Aveanna Healthcare by 207.0% in the second quarter. Squarepoint Ops LLC now owns 479,977 shares of the company's stock worth $2,510,000 after acquiring an additional 323,656 shares during the period. 87.96% of the stock is owned by institutional investors.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.